Independent

[flipper44]

Additionally, as I’ve discussed in earlier posts, in addition to the DCVax-l ten year post randomization data (which will be mature this November), I believe the Survaxm control arm data (probably primary results released this month) might be included by NWBO for any DCVax-l evidence submission to NICE, perhaps, submitted a couple/few months after (potential/imminent) DCVax-l MAA approval. JMHO.